Coronary artery disease occurring with protease inhibitor therapy

A K Sullivan, Matthew R. Nelson, Graeme Moyle, Alexa Newell, M D Feher, B G Gazzard

International Journal of STD & AIDS · 1998 · 35 citations · 0 references

Concepts

Abstract

Protease inhibitors are increasingly recognized as causing significant metabolic abnormalities including hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, diabetes, and lipodystrophy. Considerable concern has been generated by recent reports of premature coronary artery disease occurring in HIV-1 infected patients on protease inhibitor containing regimens.